Control | ENU | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NGS (this study) | NGS (this study) | Genome-wide screening1a | Transgenic reporter gene mutation assays | Endogenous gene mutation assays | ||||||||||||||||||
Target sequences | Whole exome | Whole exome | 63 loci (197 Mb) | gpt (this study) | gpt 2 | lacZ 3 | lacZ 4 | lacI 5 | Hprt (cDNA)6 | Hprt (exon 3)7 | ||||||||||||
Target tissues | Offspring | Offspring | Offspring | Sperm | Bone marow | Liver | Bone marrow | Splenic lymphocytes | Splenic lymphocytes | Splenic lymphocytes | ||||||||||||
Mutations | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | ||
Base substitution | ||||||||||||||||||||||
Transition | ||||||||||||||||||||||
G:C | to | A:T | 1 | 33.3 | 21 | 17.1 | 32 | 22.4 | 11 | 22.4 | 17 | 28.3 | 6 | 24.0 | 7 | 35.0 | 13 | 29.5 | 4 | 12.9 | 2 | 3.9 |
A:T | to | G:C | 1 | 33.3 | 52 | 42.3 | 53 | 37.1 | 8 | 16.3 | 12 | 20.0 | 1 | 4.0 | 2 | 10.0 | 10 | 22.7 | 7 | 22.6 | 14 | 27.5 |
Transversion | ||||||||||||||||||||||
G:C | to | T:A | 0 | 0.0 | 12 | 9.8 | 13 | 9.1 | 7 | 14.3 | 9 | 15.0 | 6 | 24.0 | 4 | 20.0 | 4 | 9.1 | 1 | 3.2 | 1 | 2.0 |
G:C | to | C:G | 0 | 0.0 | 0 | 0.0 | 1 | 0.7 | 1 | 2.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 2.3 | 1 | 3.2 | 0 | 0.0 |
A:T | to | T:A | 0 | 0.0 | 33 | 26.8 | 35 | 24.5 | 17 | 34.7 | 17 | 28.3 | 7 | 28.0 | 6 | 30.0 | 10 | 22.7 | 13 | 41.9 | 28 | 54.9 |
A:T | to | C:G | 0 | 0.0 | 5 | 4.1 | 8 | 5.6 | 4 | 8.2 | 3 | 5.0 | 3 | 12.0 | 0 | 0.0 | 4 | 9.1 | 5 | 16.1 | 6 | 11.8 |
Deletion | 1 | 33.3 | 0 | 0.0 | 1 | 0.7 | 1 | 2.0 | 2 | 3.3 | 1 | 4.0 | 1 | 5.0 | 1 | 2.3 | 0 | 0.0 | 0 | 0.0 | ||
Insertion | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 4.0 | 0 | 0.0 | 1 | 2.3 | 0 | 0.0 | 0 | 0.0 | ||
Total | 3 | 100 | 123 | 100 | 143 | 100 | 49 | 100 | 60 | 100 | 25 | 100 | 20 | 100 | 44 | 100 | 31 | 100 | 51 | 100 |